318 related articles for article (PubMed ID: 26501243)
1. Charting a Path to Success in Virtual Screening.
Forli S
Molecules; 2015 Oct; 20(10):18732-58. PubMed ID: 26501243
[TBL] [Abstract][Full Text] [Related]
2. Structure-based virtual screening for novel ligands.
Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
[TBL] [Abstract][Full Text] [Related]
3. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
[TBL] [Abstract][Full Text] [Related]
4. Recognizing pitfalls in virtual screening: a critical review.
Scior T; Bender A; Tresadern G; Medina-Franco JL; Martínez-Mayorga K; Langer T; Cuanalo-Contreras K; Agrafiotis DK
J Chem Inf Model; 2012 Apr; 52(4):867-81. PubMed ID: 22435959
[TBL] [Abstract][Full Text] [Related]
5. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
Daga PR; Polgar WE; Zaveri NT
J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
[TBL] [Abstract][Full Text] [Related]
6. NMR in structure-based drug design.
Carneiro MG; Ab E; Theisgen S; Siegal G
Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
[TBL] [Abstract][Full Text] [Related]
7. DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations.
Cuzzolin A; Sturlese M; Malvacio I; Ciancetta A; Moro S
Molecules; 2015 May; 20(6):9977-93. PubMed ID: 26035098
[TBL] [Abstract][Full Text] [Related]
8. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
9. Negative Image-Based Screening: Rigid Docking Using Cavity Information.
Postila PA; Kurkinen ST; Pentikäinen OT
Methods Mol Biol; 2021; 2266():125-140. PubMed ID: 33759124
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics in drug design.
Zhao H; Caflisch A
Eur J Med Chem; 2015 Feb; 91():4-14. PubMed ID: 25108504
[TBL] [Abstract][Full Text] [Related]
11. Molecular fields in ligand discovery.
Gane PJ; Chan AW
Methods Mol Biol; 2013; 1008():479-99. PubMed ID: 23729264
[TBL] [Abstract][Full Text] [Related]
12. Beware of machine learning-based scoring functions-on the danger of developing black boxes.
Gabel J; Desaphy J; Rognan D
J Chem Inf Model; 2014 Oct; 54(10):2807-15. PubMed ID: 25207678
[TBL] [Abstract][Full Text] [Related]
13. Effective screening strategy using ensembled pharmacophore models combined with cascade docking: application to p53-MDM2 interaction inhibitors.
Xue X; Wei JL; Xu LL; Xi MY; Xu XL; Liu F; Guo XK; Wang L; Zhang XJ; Zhang MY; Lu MC; Sun HP; You QD
J Chem Inf Model; 2013 Oct; 53(10):2715-29. PubMed ID: 24050442
[TBL] [Abstract][Full Text] [Related]
14. Docking and Virtual Screening in Drug Discovery.
Kontoyianni M
Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
[TBL] [Abstract][Full Text] [Related]
15. Protein structure-based drug design: from docking to molecular dynamics.
Śledź P; Caflisch A
Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
[TBL] [Abstract][Full Text] [Related]
16. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
17. An integrated virtual screening approach for VEGFR-2 inhibitors.
Zhang Y; Yang S; Jiao Y; Liu H; Yuan H; Lu S; Ran T; Yao S; Ke Z; Xu J; Xiong X; Chen Y; Lu T
J Chem Inf Model; 2013 Dec; 53(12):3163-77. PubMed ID: 24266594
[TBL] [Abstract][Full Text] [Related]
18. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
20. Structure-based computational approaches for small-molecule modulation of protein-protein interactions.
Xu D; Wang B; Meroueh SO
Methods Mol Biol; 2015; 1278():77-92. PubMed ID: 25859944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
